Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News

investors.com/news/technology/halozyme-therapeutics-medicare-inflation-reduction-act-hyaluronidase-enhanze

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.
The post Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-05-13 14:19:54.
The Entire Business World on a Single Page. Free to Use →